120 related articles for article (PubMed ID: 37605410)
1. Machine learning algorithms identify target genes and the molecular mechanism of matrine against diffuse large B-cell lymphoma.
Zhu Y; Ning Z; Li X; Lin Z
Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37605410
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the molecular mechanisms, shared gene signatures, and MicroRNAs between systemic lupus erythematosus and diffuse large B cell lymphoma by bioinformatics analysis.
Peng Z; Liang X; Lin X; Lin W; Lin Z; Wei S
Lupus; 2022 Oct; 31(11):1317-1327. PubMed ID: 35817571
[TBL] [Abstract][Full Text] [Related]
3. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway.
Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J
BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288
[TBL] [Abstract][Full Text] [Related]
4. Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation.
Huang Q; Lin J; Huang S; Shen J
Front Pharmacol; 2021; 12():787816. PubMed ID: 34955857
[No Abstract] [Full Text] [Related]
5. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
6. Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.
Li H; Yu L; Zhang X; Shang J; Duan X
Front Immunol; 2022; 13():1036239. PubMed ID: 36389761
[TBL] [Abstract][Full Text] [Related]
7. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
Zhang S; Wang H; Liu A
Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
[TBL] [Abstract][Full Text] [Related]
8. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis.
Xiang C; Ni H; Wang Z; Ji B; Wang B; Shi X; Wu W; Liu N; Gu Y; Ma D; Liu H
Front Genet; 2021; 12():756784. PubMed ID: 34721544
[TBL] [Abstract][Full Text] [Related]
9. LASSO Model Better Predicted the Prognosis of DLBCL than Random Forest Model: A Retrospective Multicenter Analysis of HHLWG.
Shen Z; Zhang S; Jiao Y; Shi Y; Zhang H; Wang F; Wang L; Zhu T; Miao Y; Sang W; Cai G; Huaihai Lymphoma WG
J Oncol; 2022; 2022():1618272. PubMed ID: 36157230
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
[TBL] [Abstract][Full Text] [Related]
11. Machine learning algorithms assisted identification of post-stroke depression associated biological features.
Zhang X; Wang X; Wang S; Zhang Y; Wang Z; Yang Q; Wang S; Cao R; Yu B; Zheng Y; Dang Y
Front Neurosci; 2023; 17():1146620. PubMed ID: 36968495
[TBL] [Abstract][Full Text] [Related]
12. Identification of Six Diagnostic Biomarkers for Chronic Lymphocytic Leukemia Based on Machine Learning Algorithms.
Zhu Y; Gan X; Qin R; Lin Z
J Oncol; 2022; 2022():3652107. PubMed ID: 36467501
[TBL] [Abstract][Full Text] [Related]
13. Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learning.
Liu C; Zhou Y; Zhou Y; Tang X; Tang L; Wang J
Comput Biol Med; 2023 Jan; 152():106388. PubMed ID: 36470144
[TBL] [Abstract][Full Text] [Related]
14. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
[TBL] [Abstract][Full Text] [Related]
15. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
[TBL] [Abstract][Full Text] [Related]
16. TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers and immune-related pathways related to immune infiltration in patients with acute myocardial infarction.
Lin Z; Xu H; Chen Y; Zhang X; Yang J
Transpl Immunol; 2022 Oct; 74():101652. PubMed ID: 35764238
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes for IgA nephropathy based on machine learning algorithm and correlation analysis of immune cells.
Chen S; Li Y; Wang G; Song L; Tan J; Yang F
Transpl Immunol; 2023 Jun; 78():101824. PubMed ID: 36948405
[TBL] [Abstract][Full Text] [Related]
19. Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma.
Li H; Zhou J; Zhou L; Zhang X; Shang J; Feng X; Yu L; Fan J; Ren J; Zhang R; Duan X
J Gene Med; 2023 Dec; 25(12):e3558. PubMed ID: 37392050
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.
Zhou L; Ding L; Gong Y; Zhao J; Xin G; Zhou R; Zhang W
PeerJ; 2020; 8():e10269. PubMed ID: 33240622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
